Last reviewed · How we verify
NCT06895681
UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
trial testing Blood Sample in Solid Tumor in 50,000 participants. Not yet recruiting.
31 December 2035
Quick facts
| Lead sponsor | University of California, San Francisco |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 50,000 |
| Start date | 31 January 2026 |
| Primary completion | 31 December 2035 |
| Estimated completion | 31 December 2035 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Blood Sample — full drug profile →
- Tissue Sample — full drug profile →
- Excess fluid Sample
- Medical Chart Review
Conditions studied
- Solid Tumor — all drugs for Solid Tumor →
- Solid Tumor, Adult — all drugs for Solid Tumor, Adult →
- Somatic Mutation — all drugs for Somatic Mutation →
- Solid Tumor, Unspecified, Adult — all drugs for Solid Tumor, Unspecified, Adult →
Sponsor
University of California, San Francisco
Who can join
18 and older, any sex, with Solid Tumor or Solid Tumor, Adult. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a non-therapeutic clinical research biorepository protocol designed to obtain, store, and clinically annotate biospecimens from participants with hereditary cancers. Those biospecimens will be used to generate participant-derived tumor models that will serve as a resource to better understand hereditary cancers and develop new efficient therapies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06895681
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood Sample
Trials testing the same drug.
- NCT07148245 — Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma · recruiting
- NCT04789551 — T Cell Profiling in Patients with Multiple Sclerosis · not yet recruiting
- NCT06962995 — Multi-Cancer Detection Observational Cohort Study · recruiting
- NCT06861244 — Embryonal Tumor With Multilayered Rosettes · Phase 2 · recruiting
- NCT06594315 — Assessing Brain Metabolism Using MRS With Deuterated Glucose · active not recruiting
Other recruiting trials for Solid Tumor
Currently open trials in the same condition.
- NCT07489378 — NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rar · recruiting
- NCT07487597 — Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors · EARLY_PHASE1 · recruiting
- NCT07382544 — Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss · Phase 1 · recruiting
- NCT07466160 — A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
- NCT07450560 — Research on Real-time Proton Therapy Guidance Through Monitoring Proton Range Using All-digital PET · active not recruiting
Other University of California, San Francisco trials
Trials by the same sponsor.
- NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
- NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
- NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
- NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
- NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06895681 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
- Last refreshed: 10 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06895681.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing